Chat with Filing

Ask questions about this document

Please log in or register to use the chat feature. Please register first.

DVA - Redcare Pharmacy's Annual General Meeting 2025: All agenda items approved; Michael Kohler and Stephan Weber new members of the Supervisory Board.

Company: Redcare Pharmacy N.V. Date: 2025-05-16 Language: English Register to download

Loading document preview...

Document Preview Not Available

The file type (.html) cannot be displayed directly here.

Open Original File

Error loading document preview. Please try the 'Open Original File' link.

You're One Click Away From The Full Filing

Instantly access this document—and 2.8M more—for free. Select your preferred method:

Continue with Google Continue with Microsoft Continue with Facebook Continue with Amazon

 News Details 

Corporate | 16 May 2025 08:31

#   

Redcare Pharmacy’s Annual General Meeting 2025: All agenda items approved; Michael Köhler and Stephan Weber new members of the Supervisory Board.

Redcare Pharmacy N.V. / Key word(s): AGM/EGM  

Redcare Pharmacy’s Annual General Meeting 2025: All agenda items approved; Michael Köhler and Stephan Weber new members of the Supervisory Board.  

  

16.05.2025 / 08:31 CET/CEST  

The issuer is solely responsible for the content of this announcement.  

  

- - -

**Redcare Pharmacy’s Annual General Meeting 2025:** **All agenda items approved; Michael Köhler and Stephan Weber new members of the Supervisory Board.**  

**Sevenum, the Netherlands, 16 May, 2025. At Redcare Pharmacy’s Annual General Meeting held yesterday, shareholders voted with an absolute majority for all agenda items, among others the appointment of Michael Köhler and Stephan Weber as new members of the Supervisory Board.**

Björn Söder, Chairman of the Supervisory Board, expresses satisfaction with the investors’ approval stating: “We are very delighted that our shareholders approved the appointments of Michael and Stephan. Both embody true entrepreneurial spirit and bring considerable industry knowledge to the Supervisory Board. They will be invaluable assets as we continue to advance our long-term strategy.”

Furthermore, the re-appointment of Jérôme Cochet as a member of the Supervisory Board for an additional and final term of one year was also approved. The Supervisory Board now consists of Björn Söder (Chairman), Jaska de Bakker (Deputy Chairwoman), Jérôme Cochet, Michael Köhler and Stephan Weber.

More information on the resolutions, including detailed voting results, can be found on Redcare Pharmacy’s corporate website in the Investor Relations section.  

**Investor Relations Contact:**  

Monica Ambrosi (Associate Director, Investor Relations)  

[investors@redcare-pharmacy.com](mailto:investors@redcare-pharmacy.com)

**Press Contact:**  

Sven Schirmer (Director, Corporate Communications)  

[press@redcare-pharmacy.com](mailto:press@redcare-pharmacy.com)

**About Redcare Pharmacy.**

Originally founded in 2001, Redcare Pharmacy N.V. (formerly known as Shop Apotheke Europe N.V.) today is the leading e-pharmacy in Europe, currently active in seven countries: Germany, Austria, France, Belgium, Italy, the Netherlands and Switzerland.

Headquartered in Sevenum, close to the Dutch city of Venlo and in the heart of Europe, the company has locations in Cologne, Berlin, Munich, Tongeren, Warsaw, Milan, Lille and Eindhoven.

As the one-stop pharmacy of the future, Redcare Pharmacy offers over 13 million active customers a wide range of more than 250,000 products at attractive and fair prices. Besides OTC, nutritional supplements, beauty and personal care products as well as an extensive assortment of health-related products in all markets, the company also provides prescription drugs for customers in Germany, Switzerland and the Netherlands.

Pharmaceutical safety is of top priority. Being a pharmacy at its core, Redcare stands for comprehensive pharmaceutical consultation service. Since care is at the heart of everything Redcare does, the company provides services for all stages of life and health. This ranges from its marketplaces to unique delivery options and medication management.

Redcare Pharmacy N.V. has been listed on the Regulated Market of the Frankfurt Stock Exchange (Prime Standard) since 2016. As of 19 June 2023, the company is a member of the MDAX selection index.

  

- - -

16.05.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News – a service of EQS Group.  

The issuer is solely responsible for the content of this announcement.  

  

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.  

Archive at www.eqs-news.com  

- - -

|     |     |
| --- | --- |
| Language: | English |
| Company: | Redcare Pharmacy N.V. |
|     | Erik de Rodeweg 11-13 |
|     | 5975 WD Sevenum |
|     | Netherlands |
| Phone: | 0800 – 200 800 300 |
| Fax: | 0800 – 90 70 90 20 |
| E-mail: | investors@redcare-pharmacy.com |
| Internet: | www.redcare-pharmacy.com |
| ISIN: | NL0012044747, DE000A19Y072 |
| WKN: | A2AR94, A19Y072 |
| Indices: | MDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 2139028 |

  

|     |     |
| --- | --- |
|     |     |
| End of News | EQS News Service |

- - -

2139028  16.05.2025 CET/CEST

![](https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=2139028&application_name=news&site_id=airport_aws~~~7cc68db1-74de-43c8-af69-2ae0a97efdc3)